Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C2G | O75747 | 5/20 | 0.75 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.75 |
| ▸ | PIK3CG | P48736 | 4/20 | 0.75 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.75 |
| ▸ | PI4KB | Q9UBF8 | 13/20 | 0.71 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14851656 | 1.00 | PIK3C2G (0.75) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB | |
| SCHEMBL14851651 | 0.93 | PIK3C2G (0.73) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB | |
| SCHEMBL16490446 | 0.90 | PIK3CG (0.63) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB | |
| SCHEMBL14851849 | 0.89 | PIK3C2G (0.79) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB | |
| SCHEMBL14851607 | 0.87 | PIK3C2G (0.82) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB | |
| SCHEMBL14851641 | 0.86 | PIK3C2G (0.80) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB | |
| SCHEMBL29420845 | 0.86 | PIK3CD (1.00) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB | |
| SCHEMBL14851574 | 0.86 | PIK3CD (1.00) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB | |
| SCHEMBL14851648 | 0.86 | PI4KB (0.81) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB | |
| SCHEMBL14851581 | 0.85 | PIK3C2G (0.79) | PIK3C2GPIK3CDPIK3CGPIK3CAPI4KB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3419980-B1 | PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY | UNIV LELAND STANFORD JUNIOR (US) | 2025-01-01 | — | — | EP | disclosed |